Methyl iodide → 1-Boc-3,4,4-trimethoxypiperidine

HRID 2168194노트

반응식

HRID 2168194 반응식
[OH:1][CH:2]1[C:7]([O:10][CH3:11])([O:8][CH3:9])[CH2:6][CH2:5][N:4]([C:12]([O:14][C:15]([CH3:18])([CH3:17])[CH3:16])=[O:13])[CH2:3]1.[CH3:19]C(C)([O-])C.[K+].CI>C1COCC1>[CH3:19][O:1][CH:2]1[C:7]([O:8][CH3:9])([O:10][CH3:11])[CH2:6][CH2:5][N:4]([C:12]([O:14][C:15]([CH3:18])([CH3:17])[CH3:16])=[O:13])[CH2:3]1

참가 물질

5

반응물 3

HCID 6328Methyl iodideHCID 11425480Tert-butyl 3-hydroxy-4,4-dimethoxypiperidine-1-carboxylateHCID 23665647Potassium tert-butoxide

생성물 1

HCID 592630891-Boc-3,4,4-trimethoxypiperidine

시약·촉매·용매 1

HCID 8028Tetrahydrofuran용매

실험 절차

To a solution of 1,1-dimethylethyl 3-hydroxy-4,4-bis(methyloxy)-1-piperidinecarboxylate D16 (11 g) in THF (150 ml) was added Potassium t-Butoxide (23.5 g, 210 mmol) at 0° C. The reaction mixture was stirred for 20 mins and the methyliodide (5.2 ml, 84 mmol) was added. The reaction mixture was allowed to warm up to room temperature and stirred overnight. The resulting mixture was concentrated and dissolved in EtOAc and washed with water. The organic layer was concentrated in vacuo to obtain crude product. Product was purified on silica gel eluting with DCM/MeOH 50/1 to obtain the desired product D17 as a yellow oil in 5 g. LCMS [MH+] [email protected] min (5 min run)

후처리

  1. stirringstirred overnight
  2. concentrationThe resulting mixture was concentrated
  3. dissolutiondissolved in EtOAc
  4. washwashed with water
  5. concentrationThe organic layer was concentrated in vacuo
  6. customto obtain crude product
  7. customProduct was purified on silica gel eluting with DCM/MeOH 50/1

출처 및 근거

ORD 기록
ord-648aa14ff4da4d168dbc693d25cf26db
출처 데이터셋
uspto-grants-2015_06
특허 번호
US09045485B2

반응 노트

불러오는 중…